Glecaprevir and Pibrentasvir
3 NDCs across 1 manufacturer|0 Generic,3 Brand
▸ More about this market▾ Less
Glecaprevir and Pibrentasvir is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $152.92 to $152.92 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$152.92 – $152.92
per EA
7d Activity
avg -0.1% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing GLECAPREVIR AND PIBRENTASVIR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MAVYRET 100-40 MG TABLET | $152.9239 per EA | -0.07% |
MAVYRET 100-40 MG TABLET | $152.9239 per EA | -0.07% |
MAVYRET 100-40 MG TABLET | $152.9239 per EA | -0.07% |
Frequently Asked Questions
How many Glecaprevir and Pibrentasvir products are on the market?
The Glecaprevir and Pibrentasvir drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Glecaprevir and Pibrentasvir?
NADAC reference prices for Glecaprevir and Pibrentasvir range from $152.9239 to $152.9239 per EA.
Which manufacturers make Glecaprevir and Pibrentasvir?
1 manufacturer lists Glecaprevir and Pibrentasvir in NADAC. Ranked by number of NDCs, the largest are AbbVie Inc. (3).
How has the price of Glecaprevir and Pibrentasvir changed recently?
Over the past 7 days, 0 Glecaprevir and Pibrentasvir NDCs rose and 6 fell, with a market-wide average change of -0.1%.